KDM2B expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.67588165567167E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
2.17048601314218E-13 |
Normal-vs-Stage2 |
1.70710999999324E-05 |
Normal-vs-Stage3 |
3.14489989605704E-10 |
Normal-vs-Stage4 |
8.17699999933197E-08 |
Stage1-vs-Stage2 |
3.284200E-01 |
Stage1-vs-Stage3 |
8.741200E-01 |
Stage1-vs-Stage4 |
8.877200E-01 |
Stage2-vs-Stage3 |
4.358800E-01 |
Stage2-vs-Stage4 |
4.930600E-01 |
Stage3-vs-Stage4 |
9.957000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
2.72337707940551E-13 |
Normal-vs-AfricanAmerican |
4.5174999963038E-08 |
Normal-vs-Asian |
4.67209999999163E-06 |
Caucasian-vs-AfricanAmerican |
2.853200E-01 |
Caucasian-vs-Asian |
1.872030E-01 |
AfricanAmerican-vs-Asian |
3.988800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
4.81359396786729E-12 |
Normal-vs-Female |
1.56541446472147E-14 |
Male-vs-Female |
9.353500E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.785440E-04 |
Normal-vs-Age(41-60Yrs) |
2.82773804372027E-13 |
Normal-vs-Age(61-80Yrs) |
1.06303854607859E-12 |
Normal-vs-Age(81-100Yrs) |
2.482500E-03 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.155600E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.675400E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.855800E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.683600E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.934220E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.469000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
5.68339997286671E-09 |
Normal-vs-Grade 2 |
6.50923759337729E-13 |
Normal-vs-Grade 3 |
4.25599555597955E-11 |
Normal-vs-Grade 4 |
1.34670000040416E-07 |
Grade 1-vs-Grade 2 |
2.554000E-02 |
Grade 1-vs-Grade 3 |
1.406160E-02 |
Grade 1-vs-Grade 4 |
1.005580E-01 |
Grade 2-vs-Grade 3 |
4.765400E-01 |
Grade 2-vs-Grade 4 |
7.624200E-01 |
Grade 3-vs-Grade 4 |
4.607200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
2.67930122532789E-11 |
Normal-vs-ccB subtype |
2.50544029967159E-12 |
ccA subtype-vs-ccB subtype |
1.149620E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
3.90476539990914E-12 |
Normal-vs-N1 |
2.876400E-03 |
N0-vs-N1 |
3.104800E-01 |
|
|